Company Filing History:
Years Active: 1983-2000
Title: E Dale Lehman: Innovator in Human Papillomavirus Research
Introduction
E Dale Lehman is a notable inventor based in Lansdale, PA (US), recognized for his contributions to the field of biotechnology. He holds a total of six patents, primarily focused on the development of recombinant proteins related to human papillomavirus (HPV). His work has significant implications for vaccine development and therapeutic interventions.
Latest Patents
Among his latest patents is the invention titled "Synthetic HPV6/11 hybrid L1 DNA encoding human papillomavirus type 11 L1." This patent details a recombinant human papillomavirus type 11 L1 protein encoded by a synthetic DNA molecule, along with methods for producing and utilizing this protein. This innovation is crucial for advancing HPV research and potential vaccine formulations.
Career Highlights
E Dale Lehman is affiliated with Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to collaborate with other experts in the field, contributing to significant advancements in HPV research and vaccine development.
Collaborations
Some of his notable coworkers include Kathryn J Hofmann and Kathrin Ute Jansen, who have worked alongside him on various projects related to HPV and recombinant protein technologies.
Conclusion
E Dale Lehman's work exemplifies the impact of innovative research in the field of biotechnology, particularly in the fight against human papillomavirus. His patents and collaborations continue to pave the way for advancements in medical science.